Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00490464 · ClinicalTrials.gov registry record
Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH
A clinical trial of Intracerebral Hemorrhage and Subarachnoid Hemorrhage, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- 163
- Enrollment target
- 1
- Study location
NCT00490464: Completed study of Intracerebral Hemorrhage and Subarachnoid Hemorrhage, sponsored by University of Illinois at Chicago.
NCT00490464 is a study of Intracerebral Hemorrhage and Subarachnoid Hemorrhage that has completed, run by University of Illinois at Chicago. The registered enrollment target is 163 participants, below the 1,101-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00490464, a study of Intracerebral Hemorrhage and Subarachnoid Hemorrhage, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- 163 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to explore ways to improve and simplify control of blood pressure in patients with SAH or ICH. This research will be done by comparing tow different medications that are routinely used to help control blood pressure. None of the medications used in this study nor any procedures performed are experimental.
Conditions Studied
Interventions
- DRUG Nicardipine and Nipride
Study Locations (1)
Illinois
- University of Illinois at Chicago, UIC - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2004-06 |
| Est. Completion | 2007-02 |
What the finished NCT00490464 record still lists
NCT00490464 is an observational study that tracks outcomes without assigning an intervention. The registered 163 participants enrollment target is mid-sized for trials with a published cap, below the 1,101-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Intracerebral Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which Nicardipine and Nipride is the first listed.
NCT00490464 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00490464 about?
NCT00490464 is a clinical study titled "Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH". The purpose of this research is to explore ways to improve and simplify control of blood pressure in patients with SAH or ICH. This research will be done by comparing tow different medications that are routinely used to help control blood pressure. None of the medications used in this study nor any ...
What is the current status of trial NCT00490464?
This trial is currently completed. The enrollment target is 163 participants. The study started on 2004-06. Estimated completion is 2007-02.
What conditions does trial NCT00490464 study?
This clinical trial studies the following conditions: Intracerebral Hemorrhage, Subarachnoid Hemorrhage.
What interventions are being tested in trial NCT00490464?
The interventions under investigation include: Nicardipine and Nipride (DRUG).
Who is sponsoring clinical trial NCT00490464?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00490464 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracerebral Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00490464's enrollment target sits among peer trials
163 18th of 31 higher than 14 of 31 other Intracerebral Hemorrhage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intracerebral Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hemodynamic ABI Monitor
RECRUITING
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
RECRUITING · Phase 3
-
Transitions of Care for Stroke Patients
RECRUITING
-
International Care Bundle Evaluation in Cerebral Hemorrhage Research
RECRUITING · Phase 4
-
ROSE-Longitudinal Assessment With Neuroimaging
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03180268 · 163 participants · Phase 3
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- NCT04862221 · 163 participants · Phase 2
TReatment for ImmUne Mediated PathopHysiology
- NCT05702229 · 163 participants · Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT06137118 · 163 participants · Phase 1
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia